Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Pain Ther.

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB, Bisney J

doi: 10.1007/s40122-018-0095-8.

Pain Relief

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

Curr Med Res Opin.

Lange B, von Zabern D, Elling C, Dubois C

doi: 10.1080/

RECOMMENDED

Back PainCancer Pain

Efficacy and safety of strong opioids for chronic non-cancer pain and chronic low back pain: a systematic review and meta-analyses

★ 3 Recommended by Dr Roland Schreiber, Faculty Member

Pain

Nury E, Schmucker C, Nagavci B, Motschall E, Nitschke K, Schulte E, Wegwarth O, Meerpohl JJ

doi: 10.1097/j.pain.0000000000002423

COMMENTED

Back PainChronic Pain

Opioids for chronic low back pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least four weeks double-blind duration

★ 3 Recommended and commented by Dr Roland Schreiber, Faculty Member

doi: 10.1002/ejp.1519.

Pain Relief

Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study

Curr Med Res Opin.

Serrie A, Lange B, Steup A

doi: 10.1080/

Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study

Eur J Pain.

Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M

doi: 10.1002/ejp.1050.

Back Pain

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

Pain.

Markman JD, Bolash RB, McAlindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer FW, Li DJ, Viktrup L, Bramson C, West CR, Verburg KM

doi: 10.1097/j.pain.0000000000001928.

Back PainChronic Pain

Stress and Self-Efficacy as Long-Term Predictors for Chronic Low Back Pain: A Prospective Longitudinal Study

J Pain Res.

Puschmann AK, Drießlein D, Beck H, Arampatzis A, Moreno Catalá M, Schiltenwolf M, Mayer F, Wippert PM

doi: 10.2147/JPR.S223893.